You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

October 7, 2020

Atthachai Homhuan Interviewed by Cannabis Law Report

Subscribe to Updates

On October 5, 2020, the Cannabis Law Report published an in-depth interview with Dr. Atthachai Homhuan, a manager in Tilleke & Gibbins’ regulatory affairs practice. The interview covers the development of Thailand’s regulatory environment for cannabis, how industry players can get involved, and Tilleke & Gibbins’ work with clients in the cannabis industry.

After giving an introduction to Tilleke & Gibbins and the firm’s work on behalf of clients in the cannabis industry, Dr. Atthachai discusses the background and current state of cannabis regulations in Thailand, and goes into the legal requirements surrounding medical cannabis, industrial hemp, and CBD-derived products. The interview then steers toward opportunities for foreign investment in Thai cannabis companies. Dr. Atthachai explains issues such as rules for cannabis companies operating in Thailand, import and export regulations, and the outlook for further foreign involvement in the Thai cannabis industry. Dr. Atthachai also demonstrates the firm’s regional capabilities by addressing the possibility of cannabis legalization in Laos and other neighboring countries.

To read the full interview, please visit the Cannabis Law Report  website.

RELATED PROFESSIONAL

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

October 12, 2012
On November 22, 2012, the Euromoney Legal Media Group will hold its second annual Asia Women in Business Law Awards at the Renaissance Harbour View Hotel in Hong Kong. Again this year, Tilleke & Gibbins stands amongst a leading group of law firms that will be recognized for their commitment to the advancement of women. The firms will be judged on a range of factors, predominately initiatives for gender diversity, innovation, mentoring, talent management, and female leadership within each firm.
Read More
September 5, 2012
Starting October 1, 2012, overseas pharmaceutical manufacturers that have never before been recorded in the Drug Product Registry of Thailand will need to be accredited by the Thai Food and Drug Administration (FDA) before marketing authorization can be obtained. Otherwise, the FDA will not allow the business operator to submit an Application for Importation of Drug Product Sample, which is a required document for drug product registration.
Read More
September 4, 2012
On September 21, 2012, Tilleke & Gibbins, together with the National Innovation Agency, will host a Thai-language seminar on “Medical Devices: Opportunities & Regulations.” The seminar with consist of three presentations, one of which will be conducted by Rarana Phanudulkitti, a consultant at Tilleke & Gibbins. With her expertise in regulatory affairs, Rarana will deal specifically with registering medical devices in Thailand, with an emphasis on best practices for companies in ensuring a smooth registration process.
Read More